Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
Stroke is the second leading cause of death and a major contributor to disability worldwide. The prevalence of stroke is highest in developing countries, with ischemic stroke being the most common type. Considerable progress has been made in our understanding of the pathophysiology of stroke and the underlying mechanisms leading to ischemic insult. Stroke therapy primarily focuses on restoring blood flow to the brain and treating stroke-induced neurological damage. Lack of success in recent clinical trials has led to significant refinement of animal models, focus-driven study design and use of new technologies in stroke research. Simultaneously, despite progress in stroke management, post-stroke care exerts a substantial impact on families, the healthcare system and the economy. Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“UMNDs may occur because of a traumatic event, nontraumatic event, or inherited or sporadic neurodegenerative disease.1,3–8”
From Feasibility, Acceptability, and Efficacy of Mindfulness Training in People With Upper Motor Neuron Disorders: A Systematic Review (2022) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedTissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundHeart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · cited 1×
“Atrial fibrillation (AF): AF is an important risk factor for stroke, increasing risk two- to five-fold depending upon the age of the individual concerned [50].”
BackgroundIntravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149 · cited 1×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491 · cited 1×
“A study reported that a 5–6 mm Hg reduction in BP lowered the relative risk of stroke by 42% [44].”
BackgroundO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“In one study, a blood pressure (BP) of at least 160/90 mmHg and a history of hypertension were considered equally important predispositions for stroke, with 54% of the stroke-affected population having these characteristics [42,43].”
BackgroundJohnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264 · cited 3×
“Primary (first-time) hemorrhages comprise the majority of strokes, with secondary (second-time) hemorrhages constituting an estimated 10–25% [2,3].”
BackgroundMethod
Research works printed but not linked: 2
- Rollin B.E. The Experimental Animal in Biomedical Research: Care, Husbandry and Well-Being: An Overview by Species Kesel M.L. CRC Press Boston, MA, USA 1995
- VE O.C. GA D. MR M. DW H. Animal models of stroke versus clinical stroke: Comparison of infarct size, cause, location, study design, and efficacy of experimental therapies Animal Models for the Study of Human Disease Michael Conn P. Academic Press Waltham, MA, USA 2013 531 568
Cited by
Items 601–700 of 1,001
Sun, Z., Wang, H., Zhao, W., & Wang, D. (2022) · Advances in Polymer Technology · doi:10.1155/2022/9999339 · Cited by 3
“Therefore, there is an urgent need to develop new treatment schemes to improve the treatment effect, especially for high-risk patients [10, 11].”
BackgroundWang, M., & Li, D. (2022) · Archives of Biological Sciences · doi:10.2298/abs220212015w · Cited by 3
Aquatic therapy in neuromotor recovery - case study
VIZITIU, E. L., Constantinescu, M. A., & Poraicu, C. (2022) · Balneo and PRM Research Journal · doi:10.12680/balneo.2022.516 · Cited by 3
Association between polymorphisms in miRNAs and ischemic stroke: A meta-analysis
Jing, Y., Hu, S., Song, J., Xu, D., Zhang, Y., Sun, X., & Wang, D. (2022) · Medicine · doi:10.1097/md.0000000000032078 · Cited by 4
tRNA Fragment biomarkers of Neurological Disease: Challenges and Opportunities
Hogg, M. C. (2023) · Medical Research Archives · doi:10.18103/mra.v11i3.3688 · Cited by 5
AI-Based Heart Disease and Brain Stroke Prediction Using Multi-modal Patient Data
Simegn, G. L., & Degu, M. Z. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-31327-1_4 · Cited by 3
Fandinata, S. S., Darmawan, R., Ulfa, N. M., & Putra, D. A. (2023) · Borneo Journal of Pharmacy · doi:10.33084/bjop.v6i1.3493 · Cited by 3
Neuroprotective effects of alkaloids
Ali, A., Martins, A. M. C., Alam, W., & Khan, H. Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824467-8.00001-2 · Cited by 6
Wang, Y., Gao, M., Zhong, Y., & Wu, B. (2023) · Polycyclic aromatic compounds · doi:10.1080/10406638.2023.2261586 · Cited by 3
“13–15 However, as a result of the narrow time window of thrombolysis ( � 4.5 h), the clinical treatment of ischemic stroke has many restrictions that need to be explored in further detail.”
InfluentialPostconditioning with D-limonene exerts neuroprotection in rats via enhancing mitochondrial activity
Zhang, L., Zhao, Z., Jia, J., Zhang, L., Xia, R., & Zhu, C. (2023) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2022-0290 · Cited by 3
Geng, Y., Liu, Y., Wang, M., Dong, X., Sun, X. H., Luo, Y., & Sun, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1320475 · Cited by 3
Brain-computer interface-based hand exoskeleton with bidirectional long short-term memory methods
Rahma, O. N., Ain, K., Putra, A. P., Rulaningtyas, R., Zalda, K., Lutfiyah, N., Alami, N. R. L., & Chai, R. (2024) · Indonesian Journal of Electrical Engineering and Computer Science · doi:10.11591/ijeecs.v34.i1.pp173-185 · Cited by 3
“Therefore, various methods have been developed in stroke management, such as antihypertensive therapy and intravenous thrombolytic drugs, to reduce the high mortality due to stroke so that life expectancy in stroke patients can increase [3].”
MethodIschemic stroke pathophysiology: A bibliometric and visualization analysis from 1990 to 2022
Bao, Y., Hu, Q., Wang, D., Ding, M., Li, W., Li, C., Lei, Z., Yang, R., & Zeng, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28597 · Cited by 4
“Ischemic stroke is a cerebrovascular disease, whose pathological feature is occlusion of the middle cerebral artery induced by the central thrombosis or embolism [1].”
BackgroundHuang, R., Zhang, L., Deng, L., & Fang, J.-O. (2024) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/185496 · Cited by 3
Mechanistic correlation of molecular pathways in obesity-mediated stroke pathogenesis
Khan, H., Tiwari, C., Kalra, P., Vyas, D., Grewal, A. K., & Singh, T. G. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00590-9 · Cited by 3
“Reduced blood flow to the brain causes extreme stress and early cell death; it also results in an embolism in an embolic stroke (necrosis) [ 47 ].”
InfluentialAnalysis of Data and Feature Processing on Stroke Prediction using Wide Range Machine Learning Model
Wisesty, U. N., Wirayuda, T. A. B., Sthevanie, F., & Rismala, R. (2024) · Jurnal Online Informatika · doi:10.15575/join.v9i1.1249 · Cited by 8
“Meanwhile, the causes of stroke at a young age include unhealthy lifestyles such as smoking and drinking alcohol, thereby increasing the risk of high blood pressure, cholesterol, and diabetes [2], [3].”
BackgroundA Machine Learning Framework for Gait and EMG Analysis for Post-stroke Motor Dysfunctions Assessment
Romano, F., Perpetuini, D., Cardone, D., & Merla, A. (2024) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-61625-9_2 · Cited by 3
Positive association of ethylene oxide levels with young stroke: a population-based study
Le, L., Lan, Z., & Chen, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1391176 · Cited by 6
“Stroke ranked among the leading causes of death globally, affecting millions each year through progressive blood vessel blockages that disrupted neurological function (Kuriakose and Xiao, 2020).”
BackgroundWu, Y., Wang, J., Wang, C., Chen, M., & Dong, H. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.07.002 · Cited by 3
Stroke: Evolution of newer treatment modalities for acute ischemic stroke
Nag, D. S., Swain, A., Sahu, S., Sen, B., Vatsala, & Parween, S. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i28.6137 · Cited by 4
A Functional Electrical Stimulation and Motor-Assisted Trike for Sport Rehabilitation Therapy
Savona, D., Zanco, C., Sanna, N., Pedrocchi, A., & Ambrosini, E. (2024) · IEEE/RAS-EMBS International Conference on Biomedical Robotics and Biomechatronics (BioRob) · doi:10.1109/biorob60516.2024.10719938 · Cited by 3
“These pathologies result in neuromotor disorders that range from partial loss of sensitivity and reduction in motor functions [2] to complete limb paralysis [3].”
BackgroundRepetitive transcranial magnetic stimulation for post-stroke epilepsy: a mini-review
Aderinto, N., Olatunji, G. D., Kokori, E., Ogieuhi, I. J., Moradeyo, A. A., Samuel, O., Babalola, A. E., Napoleon, T., Awosan, W. R., Oyewo, O., et al. (2024) · Acta Epileptologica · doi:10.1186/s42494-024-00184-1 · Cited by 3
“The damaged tissue becomes a source of abnormal electrical activity in the brain, which can lead to seizures [12].”
Association of the Triglyceride Glucose Index With Outcomes in Acute Ischemic Stroke Injury
Garg, R., Bhatnagar, M., & Gupta, S. (2024) · Cureus · doi:10.7759/cureus.75841 · Cited by 3
“It deteriorates the demand-supply ratio of oxygen and blood, causing a permanent ischemic zone with a hypoperfused zone of penumbra on the periphery [3].”
Flavonoids serve as a promising therapeutic agent for ischemic stroke
Shu, H., Liao, Q., Chen, Z., Liang, M., Zhang, S., Liu, J., Wu, Y., Hu, P., Luo, M., Zhu, W., et al. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149528 · Cited by 3
Tailoring interval training in stroke rehabilitation: The role of peak velocity
Madhavan, S., Cleland, B. T., Doshi, A., & Ozemek, C. (2025) · Journal of Rehabilitation Research and Practice · doi:10.46439/rehabilitation.6.035 · Cited by 3
Liu, J., Meng, X., He, Y., Jiang, H., Zhang, J., Shi, J., Zhang, J., Zhang, M., Cai, F., Deng, S., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1634845 · Cited by 3
Taylor, R., Opara, N. U., & Burg, J. (2021) · Cureus · doi:10.7759/cureus.20261 · Cited by 3
“The major challenges that hinder the smooth transition of pre-clinical research into successful therapeutic drug selection include confounding diseases like hypertension, diabetes, and hypercoagulable genetic disorders, age and gender effects in stroke patients, development of medical devices, investigating medical co…”
BackgroundRehabilitasi Latihan Fisik terhadap Pemulihan Pasca Stroke
Pitaloka, R. D., & Kariasa, I. M. (2021) · Jurnal Keperawatan Silampari · doi:10.31539/jks.v5i1.2975 · Cited by 3
Mapping the research trends of astrocytes in stroke: A bibliometric analysis
Ding, Z., Jiang, N., Yang, T., Han, H., Hou, M., Kumar, G., Wu, Y., Song, L., Li, X., Ma, C., et al. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.949521 · Cited by 3
“In vivo model, MCAO (Middle Cerebral Artery Occlusion) is frequently used to mimic the human ischemic stroke and displays similar penumbra (Kuriakose and Xiao, 2020), while in vitro model, OGD (Oxygen-Glucose Deprivation) allows the investigation of specific basic biochemical and molecular mechanisms under conditions…”
BackgroundMethodPadberg, I., Heel, S., Thiem, P., Diebel, A., Mordhorst, E., Strohmeyer, U., & Meisel, A. (2021) · BMC Neurology · doi:10.1186/s12883-021-02092-0 · Cited by 3
“ond leading cause of death worldwide [1].”
Managing high blood pressure in hypertensive patients with an acute ischemic stroke
Mursalov, I., Muneer, A., & Aringazina, R. A. (2022) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2022.04.001 · Cited by 3
Maes, M. H. J., Nikiforov, N. G., Plaimas, K., Suratanee, A., & Reiche, E. M. V. (2021) · Preprints.org · doi:10.20944/preprints202109.0070.v1 · Cited by 2
Li, T., Yang, L., Tu, J., Hao, Y., Zhu, Z., Xiong, Y., Gao, Q., Zhou, L., Xie, G., Zhang, D., et al. (2025) · eLife · doi:10.7554/elife.105593 · Cited by 3
Lucchetti, F., Bailo, G., Cabinio, M., Marzegan, A., Nuara, A., Rossetto, F., Squartecchia, S., Carpinella, I., Ferrarin, M., & Lencioni, T. (2025) · Scientific Data · doi:10.1038/s41597-025-06174-3 · Cited by 6
“Stroke is a neurological condition caused by disrupted blood flow to the brain, leading to brain cell damage 1 .”
Li, W., Li, T., Xi, X., Zhang, R., Sun, W., Zhang, D., Zhang, D., & Gong, W. (2023) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-022-00611-1 · Cited by 6
“Background Stroke is a disease with high morbidity and disability rate, in which about 70% of patients have hemiplegia [1].”
BackgroundOzhan, S., & Durutürk, N. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07750-y · Cited by 2
“Despite efforts to prevent stroke and reduce its incidence through early intervention, many stroke patients suffer permanent and chronic impairment that require comprehensive treatment [2, 3].”
Yeh, C., Chuang, T., Lan, M., Lin, Y.-Y., Huang, W.-H., & Hung, Y. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10155-5 · Cited by 2
Community-based models of mobility training after stroke: a scoping review
Ayelabowo, T. A., Ajayi, T. C., & Macdonald, S. H.-F. (2024) · Bulletin of Faculty of Physical Therapy · doi:10.1186/s43161-024-00226-2 · Cited by 3
Validation of the Malta Gait Scale: A Time‐Efficient Tool for Poststroke Assessment
Sarmati, V., Carmona, C., Morciano, A., Gutiérrez, S., Velásquez, I., & Fernández, J. (2025) · Stroke Research and Treatment · doi:10.1155/srat/8849857 · Cited by 2
“Stroke leads to an interruption of blood supply to the brain, depriving it of oxygen and causing signi fi cant health consequences [1].”
Shooshtari, M. K., Vastegani, S. M., Farbood, Y., Sarkaki, A., Bayati, V., Nejaddehbashi, F., Khoshnam, S. E., & Farzaneh, M. (2025) · Current Molecular Medicine · doi:10.2174/0115665240351634250506164609 · Cited by 3
Pouso, M. R., Farinha, E., Costa, H. E., Lorigo, M., Baltazar, G., & Cairrão, E. (2025) · Journal of Xenobiotics · doi:10.3390/jox15030069 · Cited by 2
“Ischemic strokes affect roughly 13.7 million people per year and are one of the leading causes of death and disability worldwide [7,11].”
InfluentialBioinformatics prediction of function of T-cell exhaustion related genes in ischemic stroke
Gao, Y., Bai, R., Gao, B., & Ma, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-03724-y · Cited by 2
Zhang, G., Hu, X., Qian, J., Shi, Y.-M., Ling, Z., Xu, P., Xu, Z., Zhang, J., & Tao, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-04863-y · Cited by 3
Fujimoto, S., Iguchi, Y., Yamagami, H., Koga, M., Itabashi, R., Yakushiji, Y., Kowata, K., Kimura, N., Terasawa, Y., Shimizu, T., et al. (2025) · Circulation Reports · doi:10.1253/circrep.cr-25-0077 · Cited by 2
Yang, L., Ding, Q., Ji, X., Lu, P., & Liu, M. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101773 · Cited by 6
“58 This condition is typically triggered by vascular blockages such as thrombi or atherosclerosis.”
Drakopoulos, M., Nadel, A., Bains, H. K., Bisen, J. B., Sikora, H., Zhang, K. X., Marchese, A., Fahey, J. D., & Mirza, R. G. (2025) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2025.07.005 · Cited by 3
Shabbir, M. S., Saeed, A., Tariq, S., Shabbir, N., Nasir, R., & Riaz, H. (2025) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2025.07.019 · Cited by 3
Li, M., Xie, W., Lv, Q., He, M., Zou, H., Hong, M., Pang, H., Cai, J., Shi, J., & Huang, W. (2025) · Technology and Health Care · doi:10.1177/09287329251363433 · Cited by 2
Wu, Y., & Liu, S. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104276 · Cited by 3
Liu, N., Peng, A., Peng, X., Xia, H., Zhang, Z., Zhang, D., Xu, S., & Xu, H. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf092 · Cited by 2
Jin, M.-M., Mao, X.-L., Song, Y.-L., Zhou, Y., Zhang, D., Zhuang, Q.-Q., Huang, X., Zhu, S.-L., He, S.-S., Chen, W., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-03046-9 · Cited by 3
“The pathophysiology of PCI is basically associated with the blockage caused by mechanical factors such as emboli and thrombi or the alterations in blood pressure, which reduces blood supply to a brain area, ultimately leading to tissue necrosis and an irreversible loss of neuronal function [5].”
Aydoğan, G., Durak, V. A., Aydoğan, A. A., Dinç, Y., Akçakoca, B., & Oral, A. Y. (2025) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.1761242 · Cited by 2
Liao, M., Zhang, S., Schwarz, M., He, C., Breitner-Busch, S., Cyrys, J., Naumann, M. K., Braadt, L., Traidl‐Hoffmann, C., Hammel, G., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109823 · Cited by 3
A narrative review on collateral circulation classification for ischemic stroke
Rahman, K. A., Ali, N. H., & Muda, A. S. (2025) · Results in Engineering · doi:10.1016/j.rineng.2025.107583 · Cited by 6
Kowiański, P., Czuba, E., & Lietzau, G. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115533 · Cited by 5
Shen, Z., Xu, Z., Liu, Q., Liu, S., & Liu, S. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01723-6 · Cited by 2
“The clinical treatment principle is to restore blood supply in a timely manner, and drugs are mainly throm - bolytic agents(Kuriakose et al., 2020;Matei et al. 2021).”
Khojah, A. M., & Dera, H. S. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1687119 · Cited by 2
E2F2 inhibits hippocampal neurogenesis in poststroke depression rats via the miR-1290/CBR1 axis
Yang, X., Zhao, X., Fu, K., Tang, B., Du, X., Liu, H., Yu, S., & Xiao, F. (2025) · Mammalian Genome · doi:10.1007/s00335-025-10177-1 · Cited by 2
“Stroke is an acute cerebrovascular disease caused by disrupted cerebral blood flow, characterized by high disability and mortality rates (Kuriakose and Xiao 2020).”
Neuritin: a multifaceted neuroprotective factor with emerging applications for neurodegeneration
Mongan, K. L., & Sharma, T. P. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1698598 · Cited by 5
Astragaloside IV is a potential natural neuroprotective agent for stroke: a review
Zhang, Q., Qin, W.-X., Li, X., Zhang, Y.-B., Li, M., Xu, J., & Mao, Z. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1718700 · Cited by 4
Hamadi, A., Mir, R., Al‐Amer, O. M., Alasseiri, M., AlZamzami, W., Alatawi, S. M., Alanazi, M. A., Moawadh, M. S., Oyouni, A. A. A., Tuwaijri, A. A., et al. (2026) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2025.1645598 · Cited by 2
“A stroke is a brain disorder with a significant cause of death worldwide (Kuriakose and Xiao, 2020).”
Zhang, W., Hou, C., Wang, X., Kang, H., Li, S., Sun, Y., Zheng, Y., Zhang, W., & Lam, S.-K. (2026) · Diagnostics · doi:10.3390/diagnostics16050807 · Cited by 1
“Stroke is one of the most prevalent aging-associated diseases worldwide [1].”
GLP-1 receptor agonists in stroke prevention: a narrative review on emerging therapeutic frontiers
Chikatimalla, R., Shah, A., Shah, T., Perry, G., Banker, H., Aggarwal, K., & Jain, R. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2660386 · Cited by 4
“The core consists of dead neural tissue, while the penumbra has a metabolically compromised yet salvageable area that serves as the primary target for neuroprotective interventions [20].”
Jiang, C., Hu, M., Pang, Y., Huang, H., Chen, T., & Xu, L. (2026) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70591 · Cited by 2
Dual-mode analysis of ischemic stroke based on urine SERS spectra and carotid B-ultrasound
Yu, W., Chen, Z., Liu, Y., Du, Y., Wang, H., Tang, F., Xie, X., & Huang, Y. (2026) · Science Advances · doi:10.1126/sciadv.aee3487 · Cited by 2
“Pathologically, IS results from the combined effects of microscopic molecular cascades (such as metabolic disorders and inflammatory stress) ( 20 , 21 ) and macroscopic local vascular lesions (such as carotid atherosclerotic plaque rupture and thrombosis) ( 13 ).”
PI3K/Akt pathway in ischemic stroke: A central regulator of neuronal survival and repair
Mariya, Khan, M. M., Badruddeen, B., & Ahmad, U. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115900 · Cited by 2
Nicolini, E., Michele, M. D., Falcou, A., Petraglia, L., Berto, I., & Toni, D. (2022) · Vessel Plus · doi:10.20517/2574-1209.2021.78 · Cited by 2
EFFECT OF MELATONIN IN POST-STROKE RECOVERY
Shreen, S., NOOREEN, N., ZAHID, U., MALEEHA, A., SAMREEN, A., & ZOHEB, M. (2022) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2022.v15i4.43466 · Cited by 2
Mei, C., & MA, T. (2022) · Physiological Research · doi:10.33549/physiolres.934849 · Cited by 2
Aldehyde Dehydrogenase Isoform 1 Predicts a Poor Prognosis of Acute Cerebral Infarction
Yang, J., Duan, J., Li, M., Sun, H., Sun, Y., Pan, W. D., & Xi, H. (2022) · Contrast Media & Molecular Imaging · doi:10.1155/2022/8199917 · Cited by 2
“It is necessary to search for noninvasive serumbiomarkers that are effective in diagnosing and predicting the progression of cerebral infarction [4, 5].”
BackgroundRisk Factors and Risk Model Construction of Stroke in Patients with Vertigo in Emergency Department
Zhu, Z., Li, Q., Wang, L., Xiao, C., Wang, H., & Xu, Y. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/2968044 · Cited by 2
“Diabetes and other metabolic abnormalities have been recognized as risk factors for stroke [7, 8].”
BackgroundO impacto das patologias clínicas neurológicas para a saúde pública
Machado, D. O. Q., Rocha, M. J. M., Machado, N. O. Q., Queiroz, H. D. F., Freitas, S. O., Alves, B. S., Diniz, F., & Mendonça, C. M. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n4-147 · Cited by 7
Haikka, S., Hyttinen, J., & Dekdouk, B. (2022) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc48229.2022.9871568 · Cited by 2
“Hemorrhages can be further divided into intracerebral where bleeding happens within the brain, and subarachnoid where the accumulation of blood happens into the subarachnoid space of the brain.[1] Stroke is the second most common cause of death worldwide, hemorrhagic having a significantly higher mortality [1].”
BackgroundEvaluation of Cerebral Microbleeds in Patients with Acute Ischemic Stroke
Ghaly, A., El-Zayat, S. A., ALI, A., & ELSHAMY, M. D. E. S. M. A. M. (2022) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.21608/aimj.2022.142376.1964 · Cited by 2
“Table (1) This table showed that 55 patients (36.”
BackgroundKlančík, V., Kočka, V., Sulženko, J., & Widimský, P. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2174101 · Cited by 2
Ganiem, L. M., Komalawati, E., Pandjaitan, R. H., & Hani, R. (2022) · Jurnal Komunikasi · doi:10.24912/jk.v14i2.18616 · Cited by 3
Acupuncture for thalamic pain after stroke: A systematic review and meta-analysis
Li, W., & Chen, S. (2023) · Medicine · doi:10.1097/md.0000000000033006 · Cited by 2
“The incidence of stroke in low-and-middle income countries is increasing year by year.[1] Thalamic pain, also known as thalamic pain syndrome, which is a typical central poststroke pain (CPSP), often follows lateral medullary stroke and parietal cortical stroke and may develop anywhere along the spinothalamic or trige…”
BackgroundCruz, C. G., Lipardo, D., Esplana, N. T. S., Loa, B. A. Q., Dismaya, M. L., Lau, J. M. Y., Quizzagan, M. C. R., Cardenas, A. B., Celso, A. T. S., Taguinod, H. L. A., et al. (2023) · Philippine Journal of Physical Therapy · doi:10.46409/002.pfeu8614 · Cited by 2
Kodama, T., & Kitai, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111668 · Cited by 3
Putra, A. P., Hidayat, A. S., Rahmatillah, A., Pujiyanto, P., Ain, K., Pawana, I. P. A., & Gusti, A. W. R. (2023) · Mathematical Modelling and Engineering Problems · doi:10.18280/mmep.100331 · Cited by 2
“Stroke is a prevalent pathological condition in the human nervous system, resulting from reduced blood supply to the brain [1].”
BackgroundKeamanan Penggunaan Antiglukolan pada Pasien Rawat Inap Stroke Iskemik dengan Atrial Fibrilasi
Mende, J., Rahmawati, F., & Puspitasari, I. (2022) · JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) · doi:10.22146/jmpf.74893 · Cited by 4
Ehsaan, F., Mumtaz, N., & Saqulain, G. (2023) · Journal of the Pakistan Medical Association · doi:10.47391/jpma.7596 · Cited by 2
Perfil dos pacientes acometidos por AVC no sul de Santa Catarina
Angelo, L. V., Domingos, N. B., Negrello, C. A., Frassetto, M. D., Sipriano, É. D. S., Mendes, J. V. S., Machado, L. V., & Madeira, K. (2023) · Revista Neurociências · doi:10.34024/rnc.2023.v31.14960 · Cited by 3
The role of platelet distribution width in the diagnosis of ischemic and hemorrhagic stroke
Demirel, M. E., & Özel, S. (2023) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.21573 · Cited by 2
Introdução da Caderneta de Saúde da Pessoa Idosa na Atenção Básica
Pinto, S. G. (2023) · Editora Conhecimento Livre eBooks · doi:10.37423/230707984 · Cited by 2
Rauniyar, V. K., Khan, S. A., Gautam, S., & Parajuli, S. B. (2023) · Medicine · doi:10.1097/md.0000000000035569 · Cited by 2
“[9] Stroke prevention is all about avoiding modifiable risk factors but management of stroke depends on treating the pathophysiology which is not very well understood.[10] Reperfusion remained the mainstay of treatment; however the efficiency of thrombolytic drugs depends on many factors including the age of the clot,…”
BackgroundCheng, X., Zhang, Z., Dong, W., Lun, Y., & Liu, B. (2023) · PubMed Central · doi:10.11817/j.issn.1672-7347.2023.220558 · Cited by 2
Classification of Acute Intracerebral Hemorrhage Using Radiomics on Brain Computed Tomography Images
Thabarsa, P., Angkurawaranon, S., Madla, C., Vuthiwong, W., Unsrisong, K., & Inkeaw, P. (2023) · doi:10.1109/icitee59582.2023.10317766 · Cited by 2
“Spontaneous nontraumatic intracerebral hemorrhage (ICH) entity accounts for 10 to 15% of all strokes and is associated with a higher mortality rate than either ischemic stroke or subarachnoid hemorrhage [1].”
BackgroundCorrelation Between Oncostatin M and Acute Ischemic Stroke: A Case-Control Study
Christian, M., Long, B., Tian, Z., Dong, Y., Huang, J., & Wei, Y. (2023) · Cureus · doi:10.7759/cureus.50297 · Cited by 5
Khaksar, S., Bigdeli, M., & Mohammadi, R. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2300732 · Cited by 2
“…excitotoxicity and imbalance in cellular homeostasis leads to triggering the intercellular signaling cascade responsible for cellular death [8]. therefore, strategies that inhibit glutamate release, increase excitatory amino acid transporters and decrease intracellular calcium probably…”
Anti-inflammatory interventions to mitigate the cardiovascular risk in metabolic syndrome
Arumugam, S., Yellurkar, M. L., Prasanna, V. S., Das, P., Sarkar, S., Das, J., Sreedhar, R., & Ravichandiran, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00003-7 · Cited by 3
Effects on Cortical Rhythms Produced by Robotic Glove Assistance During Motor Imagery
Blanco-Díaz, C. F., González-Cely, A. X., Guerrero-Méndez, C. D., de Souza, F. V., Andrade, D., & Bastos-Filho, T. (2023) · IEEE Colombian Caribbean Conference (C3) · doi:10.1109/c358072.2023.10436142 · Cited by 2
“Among these motor alterations, spasticity of the upper limbs and hands is associated with muscle weakness and decreased joint amplitude [1], [2].”
BackgroundZakharova, I. O., Bayunova, L. V., Avrova, D. K., & Avrova, N. F. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024010058 · Cited by 2
“Over the period from 1990 to 2019, the number of strokes in the world has increased significantly, claiming more lives in developing than in developed countries [2].”
Aziz, M. A. A., Razak, A. R., Farid, A. H. M., Hamid, B. A., Taha, N. A., Garraffa, M., & Alisaputri, M. L. (2024) · Medicine & health · doi:10.17576/mh.2024.1901.05 · Cited by 2
Ruan, Z., & Zhao, J. (2024) · Endocrine · doi:10.1007/s12020-024-03842-z · Cited by 3
Mulyani, L., Marjan, A. Q., Arini, F. A., & Octaria, Y. C. (2024) · Jurnal Ilmu Kesehatan Masyarakat · doi:10.26553/jikm.2024.15.1.70-84 · Cited by 2
Hyperglycemic Patterns in Acute Stroke Patients
Fountouki, A., Tegos, T. J., Ztriva, E., Kaiafa, G. D., Didangelos, T., Theofanidis, D., & Savopoulos, C. G. (2024) · Cureus · doi:10.7759/cureus.62039 · Cited by 2
“Each year, 13.7 million people are affected by stroke and approximately 5.5 million people succumb to it globally [2].”
BackgroundInfluentialStańczak, M., Wyszomirski, A., Słonimska, P., Kołodziej, B., Jabłoński, B., Stanisławska‐Sachadyn, A., & Karaszewski, B. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1399345 · Cited by 3
“Ischemic stroke is a devastating neurological condition characterized by brain tissue damage caused by sudden obstruction of blood flow in the cerebral arteries (1, 2).”
Backgroundβ2-Integrins Regulate Microglial Responses and the Functional Outcome of Hemorrhagic Stroke In Vivo
Harjunpää, H., Tallberg, R., Cui, Y., Guenther, C., Liew, H., Seelbach, A., Rubio, G. S., Airavaara, M., & Fagerholm, S. C. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300815 · Cited by 2
Li, Y., Liu, L., Yang, Z., & Xu, J. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1404570 · Cited by 2
Metadata
- Authors
- Kuriakose, D., & Xiao, Z.
- Affiliations
- Monash University (AU)
- Development and Stem Cells Program, Monash Biomedicine Discovery Institute and Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia
- ORCID
- Kuriakose, Diji
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-15
- Volume
- 21
- Issue
- 20
- Pages
- 7609
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589849
- OpenAlex
- W3093285665
- Semantic Scholar
- f44478fa13b48c2e68d010e69172d6d21ab09e66
- Cited by
- 1,350
- References
- 189
- Citations by year
- 2026: 154 · 2025: 291 · 2024: 346 · 2023: 300 · 2022: 196 · 2021: 63
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Apex Biotech Research (NA)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- stroke, ischemic stroke, stroke pathophysiology, stroke treatment, reperfusion therapy, neurological damage, animal models of stroke, stroke rehabilitation, stroke prevention, therapeutic target, post-stroke care
- MeSH terms
- Stroke Rehabilitation, Animals, Fibrinolytic Agents, Humans, Risk Factors, Neuroprotective Agents, Stroke, Stem Cell Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


